Prestige Consumer Healthcare (PBH) Capital Expenditures (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Capital Expenditures of $3.0 million in Q4 2025, up 44.05% quarter-over-quarter from $2.1 million in Q3 2025, and up 93.36% on a YoY basis from $1.6 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Capital Expenditures (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Capital Expenditures history runs 16 years deep, the most recent figure standing at $3.0 million for Q4 2025.
- In Q4 2025, Capital Expenditures rose 93.36% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $9.4 million (up 19.76% YoY), while the FY2025 annual figure was $8.2 million, down 13.88% from the prior year.
- Capital Expenditures was $3.0 million for Q4 2025 at Prestige Consumer Healthcare, up from $2.1 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $4.9 million in Q1 2021 to a low of $838000.0 in Q2 2025.
- Historically, Capital Expenditures has averaged $2.3 million across 5 years, with a median of $2.2 million in 2021.
- The sharpest annual moves came in 2021 and 2025: Capital Expenditures sank 69.64% in 2021, then jumped 93.36% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $2.2 million in 2021, then decreased by 19.11% to $1.8 million in 2022, then grew by 10.7% to $2.0 million in 2023, then fell by 21.54% to $1.6 million in 2024, then surged by 93.36% to $3.0 million in 2025.
- The last three Capital Expenditures figures came in at $3.0 million (Q4 2025), $2.1 million (Q3 2025), and $838000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | 3.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.03 Mn |
| Dec 31, 2025 | 3.03 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 838,000.00 |
| Jun 30, 2025 | 838,000.00 |
| Mar 31, 2025 | 3.48 Mn |
| Mar 31, 2025 | 3.48 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.15 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Mar 31, 2024 | 3.14 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 2.93 Mn |
| Sep 30, 2023 | 2.93 Mn |